First City Capital Management Inc. Continues to Hold Stake in Monsanto Company (MON)

First City Capital Management Inc. maintained its position in shares of Monsanto Company (NYSE:MON) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,275 shares of the basic materials company’s stock at the end of the first quarter. First City Capital Management Inc.’s holdings in Monsanto were worth $484,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Delta Asset Management LLC TN increased its position in shares of Monsanto by 0.5% in the first quarter. Delta Asset Management LLC TN now owns 1,950 shares of the basic materials company’s stock valued at $221,000 after buying an additional 10 shares in the last quarter. Savant Capital LLC increased its position in shares of Monsanto by 0.4% in the first quarter. Savant Capital LLC now owns 3,082 shares of the basic materials company’s stock valued at $349,000 after buying an additional 11 shares in the last quarter. Guardian Life Insurance Co. of America increased its position in shares of Monsanto by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,689 shares of the basic materials company’s stock valued at $191,000 after buying an additional 11 shares in the last quarter. Greenwich Wealth Management LLC increased its position in shares of Monsanto by 0.6% in the first quarter. Greenwich Wealth Management LLC now owns 2,565 shares of the basic materials company’s stock valued at $290,000 after buying an additional 15 shares in the last quarter. Finally, Dubuque Bank & Trust Co. increased its position in shares of Monsanto by 0.7% in the first quarter. Dubuque Bank & Trust Co. now owns 3,425 shares of the basic materials company’s stock valued at $388,000 after buying an additional 25 shares in the last quarter. 74.88% of the stock is currently owned by institutional investors.

Shares of Monsanto Company (NYSE MON) opened at 117.55 on Monday. The firm has a market cap of $51.64 billion, a price-to-earnings ratio of 25.39 and a beta of 1.08. The company has a 50-day moving average price of $117.56 and a 200 day moving average price of $114.47. Monsanto Company has a 52 week low of $97.35 and a 52 week high of $118.97.

Monsanto (NYSE:MON) last posted its quarterly earnings data on Wednesday, June 28th. The basic materials company reported $1.93 EPS for the quarter, topping the Zacks’ consensus estimate of $1.74 by $0.19. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The firm had revenue of $4.23 billion for the quarter, compared to analyst estimates of $4.18 billion. During the same quarter last year, the company earned $2.17 EPS. The company’s revenue was up 1.0% on a year-over-year basis. Analysts expect that Monsanto Company will post $4.89 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Shareholders of record on Friday, July 7th were paid a dividend of $0.54 per share. The ex-dividend date of this dividend was Wednesday, July 5th. This represents a $2.16 dividend on an annualized basis and a yield of 1.84%. Monsanto’s dividend payout ratio (DPR) is presently 46.75%.

TRADEMARK VIOLATION NOTICE: “[[title]]” was published by [[site]] and is the property of of [[site]]. If you are reading this piece on another domain, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The legal version of this piece can be read at [[permalink]].

Several brokerages have commented on MON. UBS AG downgraded Monsanto from a “positive” rating to a “neutral” rating in a research report on Tuesday, June 27th. BidaskClub downgraded Monsanto from a “hold” rating to a “sell” rating in a research report on Sunday, July 16th. Zacks Investment Research downgraded Monsanto from a “buy” rating to a “hold” rating in a research report on Wednesday, June 21st. BMO Capital Markets reaffirmed a “buy” rating and issued a $128.00 price target on shares of Monsanto in a research report on Wednesday, April 5th. Finally, Vetr raised Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price target on the stock in a research report on Tuesday, June 27th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and nine have issued a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $123.15.

In other Monsanto news, EVP Steven Mizell sold 11,300 shares of the firm’s stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $118.57, for a total transaction of $1,339,841.00. Following the transaction, the executive vice president now owns 55,011 shares in the company, valued at approximately $6,522,654.27. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, SVP Janet M. Holloway sold 3,337 shares of the firm’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $118.00, for a total value of $393,766.00. Following the transaction, the senior vice president now owns 44,405 shares in the company, valued at approximately $5,239,790. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 85,816 shares of company stock worth $10,117,174. Corporate insiders own 0.79% of the company’s stock.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).